Polaris Financial Partners’s Gilead Sciences GILD Stock Holding History

Polaris Financial Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12K	Buy	+78	New	+$10.9K	0.01%	269

Other funds holding GILD

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return

Montecito Bank & Trust Santa Barbara, California $660M AUM 18.73% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

First Citizens Financial Corp Mason City, Iowa $238M AUM 17.36% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $319M AUM 12.55% 1-Year Est. Return

Roxbury Financial Mount Arlington, New Jersey $130M AUM 20.04% 1-Year Est. Return

Polaris Financial Partners's GILD Position: Q3 2026 in Review

Polaris Financial Partners opened a new position in Gilead Sciences (GILD) in Q3 2026: 78 shares worth $12K. The stake represents 0.01% of the portfolio and ranks #269 among its holdings.

19 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

Polaris Financial Partners held 78 shares of Gilead Sciences worth $12K as of Q3 2026.
Gilead Sciences was a new Polaris Financial Partners position in Q3 2026.
Gilead Sciences made up 0.01% of Polaris Financial Partners's portfolio in Q3 2026, its #269 holding.
19 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Polaris Financial Partners's 13F filing for Q3 2026, filed 2 Oct 2026.